Skip to main content
PFSA
NASDAQ Industrial Applications And Services

Profusa, Inc. Files S-1 for Highly Dilutive Unit Offering Amidst Going Concern and Nasdaq Delisting Threats

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$2.69
Mkt Cap
$3.315M
52W Low
$2.65
52W High
$975.003
52W Position info
1.5% above low
Off High info
100% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

PFSA is trading near its 52-week low of $2.65 (1.5% above the low) on light trading volume (0.3× avg).

Summary

Profusa, Inc. filed an S-1 registration statement for a best-efforts offering of up to 5.1 million Units (common stock and warrants), potentially raising $14.6 million, which represents over 400% immediate dilution and is critical for the company's continued operations and Nasdaq listing compliance.


Key Events · Financing and Capital Events · PFSA

  • Highly Dilutive Unit Offering

    The company is offering up to 5,102,040 Units, each consisting of one share of common stock and two warrants, at an assumed price of $2.94 per Unit. This represents an immediate potential dilution of over 400% to existing shareholders, with total potential dilution exceeding 1600% if all warrants are exercised.

  • Critical Capital Raise

    The offering aims to raise approximately $14.6 million, which is essential for working capital and repaying $2.3 million in high-interest convertible debt, as the company faces substantial doubt about its ability to continue as a going concern.

  • Nasdaq Delisting Pressure

    This capital raise follows a 1-for-75 reverse stock split on February 9, 2026, implemented to address Nasdaq's minimum bid price requirement, with ongoing risks related to market value listing rules.

  • New Strategic Developments

    The company disclosed a new exclusive license agreement with Mayo Clinic for oxygen measurement technology and the forgiveness of a $1.3 million Paycheck Protection Program (PPP) loan, both effective February 11, 2026.


Analysis · PFSA · Industrial Applications And Services

This S-1 filing reveals a critical juncture for Profusa, Inc., as it seeks substantial capital through a highly dilutive offering. The immediate potential dilution of over 400% from the Units alone, and over 1600% if all warrants are exercised, signals severe financial distress. The $14.6 million expected proceeds are vital for the company, which explicitly states "substantial doubt about our ability to continue as a going concern" and is actively battling Nasdaq delisting threats, having recently completed a 1-for-75 reverse stock split. While the new Mayo Clinic license and the $1.3 million PPP loan forgiveness offer some positive operational and financial relief, the company's decision to invest $2.0 million in Bitcoin and its intention for it to become a "substantial majority of our assets" introduces a highly speculative and volatile element to its balance sheet, further increasing investor risk. The offering, priced at the recent market level, is a necessary but costly measure to secure short-term survival and address immediate financial and regulatory challenges.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PFSA was trading at $2.69 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.3M. The 52-week trading range was $2.65 to $975.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PFSA - Latest Insights

PFSA
Nov 13, 2026, 3:55 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.44199
Real-time Price: $0.3489 info
Change: -$0.09309 (-21%) info
Market Cap: $1.963M info
PFSA
Nov 12, 2026, 7:30 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.7158
Real-time Price: $0.3489 info
Change: -$0.3669 (-51%) info
Market Cap: $1.963M info
PFSA
Nov 10, 2026, 5:09 PM EST
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.5203
Real-time Price: $0.3489 info
Change: -$0.1714 (-33%) info
Market Cap: $1.963M info
PFSA
Nov 06, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.530
Real-time Price: $0.3489 info
Change: -$0.1811 (-34%) info
Market Cap: $1.963M info
PFSA
Oct 15, 2026, 6:10 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.26
Real-time Price: $0.3489 info
Change: -$0.9111 (-72%) info
Market Cap: $1.963M info